Sage Therapeutics, Inc.
SAGE
Revenue
11.87M
▲3.22M▲37.17%
3 Months ChangeAssets
622.43M
▼-74.67M▼-10.71%
3 Months ChangeLiabilities
70.60M
▲1.55M▲2.25%
3 Months ChangeFree Cash Flow
-37.83M
▲116.08M▲75.42%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001193125-24-249830
2024-10-29
Form 10-Q
ID: 0000950170-24-118256
2024-10-29
Form 8-K
ID: 0001193125-24-246535
2024-10-17
Form 8-K
ID: 0001193125-24-238425
2024-10-08
Form 8-K
ID: 0001193125-24-234111
2024-09-26
Form 8-K
ID: 0001193125-24-226479
2024-07-31
Form 10-Q
ID: 0000950170-24-088593
2024-07-31
Form 8-K
ID: 0001193125-24-189930
2024-07-24
Form 8-K
ID: 0001193125-24-183284
2024-06-11
Form 8-K
ID: 0001193125-24-159130